Regulation of extracellular matrix remodeling following transforming growth factor-β1/epidermal growth factor-stimulated epithelial-mesenchymal transition in human premalignant keratinocytes

Cells Tissues Organs

Volumn 185, Issue 1-3, 2007, Pages 116-122

  Wilkins Port, Cynthia E ^a   Higgins, Paul J ^a,b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b Center for Cell Biology and Cancer Research   (United States)

Author keywords

Epidermal growth factor; Epithelial mesenchymal transition; Extracellular matrix; Matrix metalloproteinase; Transforming growth factor

Indexed keywords

COLLAGEN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; STROMELYSIN 2; TRANSFORMING GROWTH FACTOR BETA1;

CANCER DIAGNOSIS; CONFERENCE PAPER; ESOPHAGUS CANCER; EXTRACELLULAR MATRIX; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; KERATINOCYTE; MOUTH CAVITY; PHENOTYPE; PRECANCER; PRIORITY JOURNAL; PROTEIN DEGRADATION; SKIN CANCER; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH;

EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; EPITHELIUM; EXTRACELLULAR MATRIX; HUMANS; KERATINOCYTES; MESODERM; MODELS, BIOLOGICAL; PRECANCEROUS CONDITIONS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 34250693511     PISSN: 14226405     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101312     Document Type: Conference Paper

References (65)

1. Ahokas, K., J. Lohi, S.A. Illman, E. Llano, O. Elomaa, U. Impola, M.-L. Karjalainen-Lindsberg, U. Saarialho-Kere (2003) Matrix metalloproteinase-21 is expressed epithelially during development and in cancer and is upregulated by transforming growth factor-β1 in keratinocytes. Lab Invest 83: 1887-1899.
2. Allen, R.R., P.J. Higgins (2004) Plasminogen activator inhibitor type-1 expression and the pathophysiology of TGF-β1-incuced epithelial-to- mesechymal transition. Recent Res Dev Physiol 2: 355-366.
3. Andreasen, P.A., L. Kjøller, L. Christensen, M.J. Duffy (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72: 1-22.
4. Bacharach, E., A. Itin, E. Keshet (1998) Apposition-dependent induction of plasminogen activator inhibitor type 1 expression: a mechanism for balancing pericellular proteolysis during angiogenesis. Blood 92: 939-945.
5. Bajou, K., V. Masson, R.D. Gerard, P.M. Schmitt, V. Albert, J. Praus, L.R. Lund, T.L. Frandsen, N. Brunner, K. Dano, N.E. Fusenig, U. Weidle, G. Carmeliet, D. Loskutoff, D. Collen, P. Carmeliet, J.M. Foidart, A. Noel (2001) The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies. J Cell Biol 152: 777-784.
6. Bajou, K., A. Noel, R.D. Gerard, V. Masson, N. Brunner, C. Holst-Hansen, M. Skobe, N.E. Fusenig, P. Carmeliet, D. Collen, J.M. Foidart (1998) Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 4: 923-928.
7. Boyer, B., A.M. Valles, N. Edme (2000) Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 60: 1091-1099.
8. Chakraborti, S., M. Mandal, S. Das, A. Mandal, T. Chakraborti (2003) Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem 253: 269-285.
9. Chen, L.L., R. Narayanan, M.S. Hibbs, P.A. Benn, M.L. Clawson, G. Lu, J.S. Rhim, B. Greenberg, J. Mendelsohn (1993) Altered epidermal growth factor signal transduction in activated Ha-ras transformed human keratinocytes. Biochem Biophys Res Commun 193: 167-174.
10. Chin, D., G.M. Boyle, P.G. Parsons, W.B. Coman (2004) What is transforming growth factor-beta (TGF-β)? Br J Plast Surg 57: 215-221.
11. Cho, N.H., K.P. Hong, S.H. Hong, S. Kang, K.Y. Chung, S.H. Cho (2004) MMP expression profiling in recurred stage IB lung cancer. Oncogene 23: 845-851.
12. Davies, M., M. Robinson, E. Smith, S. Huntley, S. Prime, I. Paterson (2005) Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-β1 involves MAPK, Smad and AP-1 signaling pathways. J Cell Biochem 95: 918-931.
13. Derynck, R., R.J. Akhurst, A. Balmain (2001) TGF-βsignaling in tumor suppression and cancer progression. Nat Genet 29: 117-129.
14. Fusenig, N.E., P. Boukamp (1998) multiple stages and genetic alterations in immortalization, malignant transformation and tumor progression of human skin keratinocytes. Mol Carcinog 23: 144-158.
15. Gill, J.H., I.G. Kirwan, J.M. Seargent, S.W. Martin, S. Tijani, V.A. Anikin, A.J. Mearns, M.C. Bibby, A. Anthoney, P.M. Loadman (2004) MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic in human lung carcinomas. Neoplasia 6: 777-785.
16. Go, C., P. Li, X.-J. Wang (1999) Blocking transforming growth factor β signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis. Cancer Res 59: 2861-2868.
17. Gotzmann, J., M. Mikula, A. Eger, R. Schulte-Hermann, R. Foisner, H. Beug, W. Mikulits (2004) Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res 566: 9-20.
18. Grünert, S., M. Jechlinger, H. Beug (2003) Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol 4: 657-665.
19. Hahn, S.A., M. Schutte, A.T.M. Shamsul Hoque, C.A. Moskaluk, L.T. da Costa, E. Rozenblum, C.L. Weinstein, A. Fischer, C.J. Yeo, R.H. Hruban, S.E. Kern (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353.
20. Han, G., S.-L. Lu, A.G. Li, W. He, C.L. Corless, M. Kulesz-Martin, X. Wang (2005) Distinct mechanisms of TGF-β1-mediated epithelial-to- mesenchymal transition and metastasis during skin carcinogenesis. J Clin Invest 115: 1714-1723.
21. Hay, E.D. (2005) The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn 233: 706-720.
22. Huber, M.A., N. Kraut, H. Beug (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558.
23. Hundsdorfer, R., H.-F. Zeilhofer, K.P. Bock, P. Dettmar, M. Schmitt, A. Kolk, C. Pautke, H.-H. Horch (2005) Tumour-associated urokinase-type plasminogen activator (uPA) and its inhibitor PAI-1 in normal and neoplastic tissues of patients with squamous cell cancer of the oral cavity - clinical relevance and prognostic value. J Craniomaxillofac Surg 33: 191-196.
24. Impola, U., V.J. Uitto, J. Hietanen, L. Hakkinen, L. Zhang, H. Larjava, H. Isaka, U. Saarialho-Kere (2004) Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 202: 14-22.
25. Isseroff, R.R., D.B. Rifkin (1983) Plasminogen is present in the basal layer of the epidermis. J Invest Dermatol 80: 297-299.
26. Johansson, N., J. Westermarck, S. Leppa, L. Hakkinen, L. Kiovisto, C. Lopez-Otin, J. Peltonen, J. Heino, V.M. Kahari (1997) Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor alpha and transforming growth factor beta. Cell Growth Differ 8: 243-250.
27. Kalluri, R., E.G. Neilson (2003) Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 112: 1776-1784.
28. Kerkelä, E., R. Ala-aho, L. Jeskanen, J. Lohi, R. Grénman, V.M. Kähäri, U. Saarialho-Kere (2001) Differential patterns of stromelysin-2 (MMP-10) and MT1-MMP (MMP-14) expression in epithelial skin cancers. Br J Cancer 84: 659-669.
29. Khew-Goodhall, Y., C. Wadham (2005) A perspective on regulation of cell-cell adhesion and epithelial-mesenchymal transition: known and novel. Cells Tissues Organs 179: 81-86.
30. Kim, E.S., M.S. Kim, A. Moon (2004a) TGFbeta-induced upregulation of MMP-2 and MMP-9 depends on p38 MAPK, but not ERK signaling in MCF10A human breast epithelial cells. Int J Oncol 25: 1375-1382.
31. Kim, E.-S., M.-S. Kim, A. Moon (2005) Transforming growth factor (TGF)-β in conjunction with H-ras activation promotes malignant progression of MCF10A breast epithelial cells. Cytokine 29: 84-91.
32. Kim, H.S., T. Shang, Z. Chen, S.C. Pflugfelder, D.Q. Li (2004b) TBF-beta1 stimulates production of gelatinase (MMP-9), collagenases (MMP-1, -13) and stromelysins (MMP-3, -10, -11) by human corneal epithelial cells. Exp Eye Res 79: 263-274.
33. Krampert, M., W. Bloch, T. Sasaki, P. Bugnon, T. Rülicke, E. Wolf, M. Aumailley, W.C. Parks, S. Werner (2004) Activities of the matrix metalloproteinase stromelysin-2 (MMP-10) in matrix degradation and keratinocyte organization in wounded skin. Mol Biol Cell 15: 5242-5254.
34. Kutz, S.M., C.E. Higgins, R. Samarakoon, S.P. Higgins, R.R. Allen, L. Qi, P.J. Higgins (2006) TGF-β1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling. Exp Cell Res 312: 1093-1105.
35. Lijnen, H.R. (2002) Matrix metalloproteinases and cellular fibrinolytic activity. Biochemistry 67: 92-98.
36. Madlener, M., C. Mauch, W. Conca, M. Brauchle, W.C. Parks, S. Werner (1996) Regulation of the expression of stromelysin-2 by growth factors in keratinocytes: implications for normal and impaired wound healing. Biochem J 320: 659-664.
37. Mathew, R., R. Khanna, R. Kumar, M. Mathur, N.K. Shukla, R. Ralhan (2002) Stromelysin-2 overexpression in human esophageal squamous cell carcinoma: potential clinical implications. Cancer Detect Prev 26: 222-228.
38. Munshi, H.G., Y.I. Wu, S. Mukhopadhyay, A.J. Ottaviano, A. Sassano, J.E. Koblinski, L.C. Platanias, M.S. Stack (2004) Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK1/2 and p38 MAPK-modulated tissue inhibitor of metalloproteinase 2 expression controls transforming growth factor-β1 induced pericellular collagenolysis. J Biol Chem 279: 39042-39050.
39. Nawshad, A., D. LaGamba, A. Polad, E.D. Hay (2005) Transforming growth factor-β signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis. Cells Tissues Organs 179: 11-23.
40. Newman, M.J. (1993) Transforming growth factor beta and the cell surface in tumor progression. Cancer Metastasis Rev 12: 239-254.
41. O-charoenrat, P., P.H. Rhys-Evans, D.J. Archer, S.A. Eccles (2002) C-erbB receptors in squamous cell carcinomas of the head and neck: clinical significance and correlation with matrix metalloproteinases and vascular endothelial growth factors. Oral Oncol 38: 73-80.
42. O-charoenrat, P., P.H. Rhys-Evans, S.A. Eccles (2001) Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 127: 813-820.
43. O-charoenrat, P., P. Rhys-Evans, H. Modjtahedi, W. Court, G. Box, S. Eccles (2000) Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion. Int J Cancer 86: 307-317.
44. Portella, G., S.A. Cumming, J. Liddell, W. Cui, H. Ireland, R.J. Akhurst, A. Balmain (1998) Transforming growth factor β is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumor invasion. Cell Growth Differ 9: 393-404.
45. Rechardt, O., O. Elomaa, M. Vaalamo, K. Pääkkönen, T. Jahkola, J. Höök-Nikanne, R.M. Hembry, L. Häkkinen, J. Kere, U. Saarialho-Kere (2000) Stromelysin-2 is upregulated during normal wound repair and is induced by cytokines. J Invest Dermatol 115: 778-787.
46. Rho, O., L.M. Beltran, I.B. Gimenez-Conti, J. DeGiovanni (1994) Altered expression of the epidermal growth factor receptor and transforming growth factor-alpha during multistage skin carcinogenesis in SENCAR mice. Mol Carcinog 11: 19-28.
47. Roberts, A.B., B.K. McCune, M.B. Sporn (1992) TGF-beta: regulation of extracellular matrix. Kidney Int 41: 557-559.
48. Roberts, A.B., L.M. Wakefield (2003) The two faces of transforming growth factor β in carcinogenesis. Proc Natl Acad Sci USA 100: 8621-8623.
49. Salmela, M.T., S.L. Pender, M.L. Karjalainen-Lindsberg, P. Puolakkainen, T.T. Macdonald, U. Saarialho-Kere (2004) Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing. Scand J Gastroenterol 39: 1095-1104.
50. Sato, T., M. Iwai, T. Sakai, H. Sato, M. Seiki, Y. Mori, A. Ito (1999) Enhancement of membrane-type 1-matrix metalloproteinase (MT1-MMP) production and sequential activation of progelatinase A on human squamous carcinoma cells co-cultured with human dermal fibroblasts. Br J Cancer 80: 1137-1143.
51. Savagner, P. (2001) Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 23: 912-923.
52. Streuli, C.H., C. Schmidhauser, M. Kobrin, M.J. Bissell, R. Derynck (1993) Extracellular matrix regulates expression of the TGF-β1 gene. J Cell Biol 120: 253-260.
53. Sudbeck, B.D., P. Baumann, G.J. Ryan, K. Breitkopf, R. Nischt, T. Krieg, C. Mauch (1999) Selective loss of PMA-stimulated expression of matrix metalloproteinase 1 in HaCaT keratinocytes is correlated with the inability to induce mitogen-activated protein family kinases. Biochem J 339: 167-175.
54. Thiery, J.P. (2002) Epithelial-mesenchymal transitions in tumor progression. Nat Rev Cancer 2: 442-454.
55. Thiery, J.P. (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15: 740-746.
56. Thiery, J.P., J.P. Sleeman (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142.
57. Thompson, E.W., D.F. Newgreen (2005) Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 65: 5991-5995.
58. Vollberg Sr., T.M., M.D. George, A.M. Jetten (1991) Induction of extracellular matrix gene expression in normal human keratinocytes by transforming growth factor β is altered by cellular differentiation. Exp Cell Res 193: 93-100.
59. Wakefield, L.M., A.B. Roberts (2002) TGF-β signaling: positive and negative effects on tumorigenesis. Curr Opin Genet Dev 12: 22-29.
60. Wikner, N.E., J.T. Elder, K.A. Persichitte, P. Mink, R.A.F. Clark (1990) Transforming growth factor-β modulates plasminogen activator activity and plasminogen activator type-1 expression in human keratinocytes in vitro. J Invest Dermatol 95: 607-613.
61. Wilkins-Port, C.E., J. Freytag, P.J. Higgins (2005) TGFβ1/EGF modulate pericellular proteolysis by stimulating collagenolytic activity in pre-malignant human epidermal keratinocytes (abstract). Epithelial Mesenchymal Transition (EMT) Conference, Vancouver.
62. Windsor, L.J., H. Grenett, B. Birkedal-Hansen, M.K. Bodden, J.A. Engler, H. Birkedal-Hansen (1993) Cell type-specific regulation of SL-1 and SL-2 genes. J Biol Chem 268: 17341-17347.
63. Wright, J.A., E.A. Turley, A.H. Greenberg (1993) Transforming growth factor beta and fibroblast growth factor as promoters of tumor progression to malignancy. Crit Rev Oncog 4: 473-492.
64. Yuspa, S.H. (1998) The pathogenesis of squamous cell cancer: lessons learned from studies of skin carcinogenesis. J Dermatol Sci 17: 1-7.
65. Zavadil, J., M. Bitzer, D. Liang, Y.-C. Yang, A. Massimi, S. Kneitz, E. Piek, E.P. Böttinger (2001) Genetic programs of epithelial cell plasticity directed by transforming growth factor-β. Proc Natl Acad Sci USA 98: 6686-6691.